Trials / Recruiting
RecruitingNCT06185205
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.
Detailed description
This phase 2, single-arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a short course over 1.5 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Accelerated partial breast irradiation | High Dose Rate treatment delivery |
Timeline
- Start date
- 2023-12-12
- Primary completion
- 2031-01-31
- Completion
- 2033-01-31
- First posted
- 2023-12-29
- Last updated
- 2025-11-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06185205. Inclusion in this directory is not an endorsement.